Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Vertex Pharmaceuticals (Sweden) AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 59,001 Less Arrow 48,822 Less Arrow 44,005
Financial expenses 336 Less Arrow 108 Less Arrow 0
Earnings before taxes 3,882 Less Arrow 3,270 Less Arrow 3,033
EBITDA 4,670 Less Arrow 3,395 Less Arrow 3,339
Total assets 33,035 More Arrow 61,995 Less Arrow 39,894
Current assets 32,763 More Arrow 61,250 Less Arrow 39,388
Current liabilities 16,462 More Arrow 49,191 Less Arrow 29,275
Equity capital 16,573 Less Arrow 12,804 Less Arrow 10,619
- share capital 51 Less Arrow 47 More Arrow 49
Employees (average) 9 Less Arrow 7 Equal arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 50.2% Less Arrow 20.7% More Arrow 26.6%
Turnover per employee 6,556 More Arrow 6,975 Less Arrow 6,286
Profit as a percentage of turnover 6.6% More Arrow 6.7% More Arrow 6.9%
Return on assets (ROA) 12.8% Less Arrow 5.4% More Arrow 7.6%
Current ratio 199.0% Less Arrow 124.5% More Arrow 134.5%
Return on equity (ROE) 23.4% More Arrow 25.5% More Arrow 28.6%
Change turnover 6,714 Less Arrow 6,140 Less Arrow -15,336
Change turnover % 13% More Arrow 14% Less Arrow -26%
Chg. No. of employees 2 Less Arrow 0 Less Arrow -1
Chg. No. of employees % 29% Less Arrow 0% Less Arrow -13%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.